JBP1 Antibody

Shipped with Ice Packs
In Stock

Description

JBP1 Functional Overview

JBP1 catalyzes the hydroxylation of thymine in DNA to form hydroxymethyluracil (hmU), a precursor to base J. This modification is essential for regulating transcription termination and chromatin structure in kinetoplastid parasites . Key properties include:

  • Dioxygenase Activity: Requires Fe²⁺ and 2-oxoglutarate (2-OG) for enzymatic function .

  • DNA Binding Specificity: Recognizes J-containing DNA (J-DNA) with 10,000-fold preference over unmodified DNA via a helical bouquet fold domain (DB-JBP1) .

  • Role in Pathogenesis: Essential in Leishmania for maintaining genomic J levels but dispensable in T. brucei, where its absence reduces J levels by ~95% .

DNA Recognition Mechanism

The DB-JBP1 domain (residues 460–620) mediates J-DNA binding through:

  • A conserved Asp525 residue critical for J-DNA specificity .

  • A "ribbon" helix that undergoes conformational changes upon J-DNA binding .

FeatureDescription
Domain StructureHelix-turn-helix variant fold with a flexible "ribbon" helix
Key MutationsAsp525 → Ala abolishes J-DNA binding specificity
Binding Affinity13–140 nM for J-DNA vs. 1370 nM for thymine-containing DNA

Enzymatic Activity

JBP1 functions as a thymidine hydroxylase (TH), converting thymine to hmU in duplex DNA . This activity is abolished by mutations in Fe²⁺/2-OG-binding residues (e.g., His487, Arg510) .

Experimental Tools and Antibody Context

While no JBP1-specific antibody is described in the provided sources, related methodologies include:

  • Anti-J Antibodies: Used to immunoprecipitate J-DNA in chromatin studies .

  • Recombinant JBP1: Purified for in vitro assays (e.g., fluorescence anisotropy, hydroxylation activity) .

Key Assays Involving JBP1

Assay TypeApplication
Fluorescence PolarizationQuantified J-DNA binding affinity (~13 nM)
Hydrogen/Deuterium ExchangeMapped J-DNA-induced conformational changes in DB-JBP1
Complementation StudiesValidated JBP1’s role in maintaining J levels in Leishmania and T. brucei

Therapeutic Implications

Disruption of JBP1-J-DNA interaction is a potential target for antiparasitic drugs. For example:

  • Mutating Asp525 or inhibiting Fe²⁺/2-OG cofactors blocks J biosynthesis .

  • T. brucei JBP1/2 double knockouts lack base J entirely, enabling functional studies of J-deficient parasites .

Research Gaps and Future Directions

  • Antibody Development: No JBP1-specific antibodies are reported here, highlighting a need for tools to study JBP1 localization and protein interactions.

  • Mechanistic Details: The interplay between JBP1 and JBP2 in de novo J synthesis remains unresolved .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
12-14 week lead time (made-to-order)
Synonyms
Thymine dioxygenase JBP1 (EC 1.14.11.6) (J-binding protein 1) (Thymidine hydroxylase JBP1), JBP1
Target Names
JBP1
Uniprot No.

Target Background

Function
JBP1 is a dioxygenase catalyzing the initial step in DNA base J (β-D-glucosyl-HOMedU) biosynthesis. This enzyme converts thymine to 5-hydroxymethyluracil (HOMedU). Base J, a hypermodified thymidine residue found primarily in kinetoplastid parasite telomeric repetitive DNA, is implicated in antigenic variation regulation. JBP1 also exhibits specific binding affinity for base J-containing DNA (J-DNA). Its role extends to propagating and maintaining J synthesis initiated by JBP2, achieved through specific binding to pre-existing base J and subsequent synthesis propagation. Importantly, thymine dioxygenase activity and J-DNA binding are independent functions.
Database Links
Protein Families
TET family, JBP1 subfamily
Subcellular Location
Nucleus.

Q&A

What is JBP1 and why is it significant for research?

JBP1 is a protein that binds to DNA base J in trypanosomatids. Research has established that JBP1 functions as a thymidine hydroxylase, responsible for converting thymine specifically in double-stranded DNA to hydroxymethyluracil (hmU) in an Fe²⁺/2-oxoglutarate-dependent manner . This enzymatic activity makes JBP1 crucial for understanding unique DNA modification processes in trypanosomatid parasites. The significance of JBP1 extends beyond its enzymatic function, as it works alongside JBP2 in a two-step process for J-biosynthesis, with JBP1 playing a key role in amplifying basal levels of J initially established by JBP2 .

What are the primary applications of JBP1 antibodies in research?

JBP1 antibodies are essential tools for multiple research applications including:

  • Detection and quantification of JBP1 protein through Western blotting

  • Immunolocalization studies to determine subcellular distribution

  • Chromatin immunoprecipitation (ChIP) to study JBP1-DNA interactions

  • Co-immunoprecipitation to identify JBP1 protein interaction partners

  • Flow cytometry analysis of JBP1 in cell populations

These applications enable researchers to investigate the functional roles of JBP1 in base J synthesis and the biological consequences of this DNA modification across different experimental contexts .

How should JBP1 antibodies be stored and handled for optimal performance?

For maintaining antibody integrity and performance, JBP1 antibodies should typically be stored at -20°C for routine use, with long-term storage recommended at -80°C . Avoid repeated freeze-thaw cycles, which can compromise antibody activity. Most commercial antibodies are supplied in phosphate-buffered saline (PBS) at pH 7.5 with sodium azide (0.05%) as a preservative . When handling antibodies, use appropriate personal protective equipment and maintain sterile conditions to prevent contamination.

What controls should be included when using JBP1 antibodies?

When conducting experiments with JBP1 antibodies, several controls are essential:

  • Positive control: Lysates or samples from wild-type cells known to express JBP1

  • Negative control: Samples from JBP1 knockout or null cells (JBP1⁻/⁻)

  • Isotype control: Non-specific antibody of the same isotype and host species

  • Peptide competition assay: Pre-incubation of antibody with excess JBP1 peptide/protein

  • Secondary antibody-only control: To assess non-specific binding

These controls are particularly important given the specificity requirements for distinguishing JBP1 from other proteins, including the related JBP2 .

What are the optimized protocols for using JBP1 antibodies in Western blotting?

For effective Western blotting with JBP1 antibodies:

  • Sample preparation: Lyse cells in an appropriate buffer (e.g., RIPA) containing protease inhibitors

  • Protein quantification: Use BCA or Bradford assay to ensure equal loading

  • SDS-PAGE: Typically use 8-10% gels for JBP1 (molecular weight considerations)

  • Transfer: PVDF membranes are recommended for optimal protein binding

  • Blocking: 5% non-fat milk or BSA in TBST (1-2 hours at room temperature)

  • Primary antibody incubation: Dilute JBP1 antibody 1:500 to 1:2000 in blocking buffer, incubate overnight at 4°C

  • Washing: 3-5 washes with TBST, 5-10 minutes each

  • Secondary antibody: HRP-conjugated anti-rabbit IgG (if using rabbit polyclonal JBP1 antibody)

  • Detection: Enhanced chemiluminescence (ECL) system

The specific dilution and incubation conditions may need optimization based on the particular antibody used and sample characteristics .

How can JBP1 antibodies be effectively used in immunoprecipitation experiments?

For immunoprecipitation (IP) with JBP1 antibodies:

  • Cell lysis: Use gentle lysis buffers (e.g., 50 mM HEPES, 100 mM NaCl, 0.5% NP-40) with protease inhibitors

  • Pre-clearing: Incubate lysate with protein A/G beads to remove non-specific binding proteins

  • Antibody binding: Add 2-5 μg of JBP1 antibody per 500 μg of protein lysate, incubate overnight at 4°C with gentle rotation

  • Immunoprecipitation: Add fresh protein A/G beads, incubate 2-4 hours at 4°C

  • Washing: Wash beads 4-5 times with lysis buffer

  • Elution: Use SDS sample buffer or gentle elution buffer depending on downstream applications

  • Analysis: Western blot, mass spectrometry, or other techniques

For co-IP experiments, use lower stringency wash buffers to preserve protein-protein interactions .

How can JBP1 antibodies be used to investigate the relationship between JBP1 and JBP2?

Investigating JBP1-JBP2 functional relationships requires sophisticated approaches:

  • Sequential ChIP (ChIP-reChIP): Using antibodies against both JBP1 and JBP2 to identify regions where both proteins co-localize

  • Co-immunoprecipitation: JBP1 antibodies can be used to pull down JBP1 and associated proteins, followed by Western blotting for JBP2

  • Proximity ligation assay (PLA): To visualize and quantify JBP1-JBP2 protein interactions in situ

  • Comparative ChIP-seq: Analyze genome-wide binding patterns of JBP1 versus JBP2

  • Knockout/complementation studies: Use JBP1/JBP2 double knockout cells with selective re-expression of either protein

Research has shown that JBP1 and JBP2 have distinct but complementary roles in J biosynthesis; JBP2 initiates site-specific J synthesis, while JBP1 amplifies J levels at these specific sites .

What are effective methods for validating JBP1 antibody specificity?

To ensure JBP1 antibody specificity:

  • Western blot analysis: Compare wild-type versus JBP1 knockout samples

  • Competition assays: Pre-incubate antibody with purified recombinant JBP1 protein

  • Multiple antibody validation: Use different antibodies targeting distinct JBP1 epitopes

  • siRNA/knockout validation: Check for signal reduction after JBP1 knockdown/knockout

  • Mass spectrometry: Confirm identity of immunoprecipitated proteins

  • Cross-reactivity testing: Test against related proteins (especially JBP2)

Validation is particularly important given the structural and functional similarities between JBP1 and JBP2, as both are thymidine hydroxylases involved in J biosynthesis .

How can JBP1 antibodies be used to detect hydroxymethyluracil (hmU) formation?

While JBP1 antibodies target the protein itself, detecting the product of JBP1 activity (hmU) requires different approaches:

  • In vitro TH (thymidine hydroxylase) assay: Incubate recombinant JBP1 with duplex DNA in the presence of Fe²⁺, 2-oxoglutarate, and ascorbic acid, then detect hmU formation using:

    • Anti-hmU pulldown assay: Highly specific for hmU over base J or unmodified thymidine

    • LC-MS/MS analysis: For precise quantification of hmU in DNA samples

  • Experimental considerations:

    • The reaction depends on Fe²⁺, 2-oxoglutarate (2-OG), and O₂

    • JBP1 hydroxylates thymine specifically in double-stranded DNA

    • In vitro conversion rates are relatively low (approximately 7 lesions/10⁴ dT)

These methods have revealed that JBP1-mediated hydroxylation is highly specific for double-stranded DNA contexts, correlating with the specificity of the J-DNA binding domain at the C-terminus of JBP1 .

How can JBP1 antibodies contribute to understanding base J biosynthesis and function?

JBP1 antibodies enable several approaches to study the J biosynthesis pathway:

  • Chromatin immunoprecipitation (ChIP): Identify genomic regions where JBP1 binds and initiates J formation

  • Immunofluorescence microscopy: Visualize JBP1 localization during different cell cycle stages or life cycle phases

  • Protein complex analysis: Identify proteins that interact with JBP1 during J biosynthesis

  • In vitro reconstitution: Using purified components including JBP1 to reconstruct the J biosynthesis pathway

Research using these approaches has revealed that JBP1 operates optimally in internal regions involved in RNA polymerase II transcription, while JBP2 functions preferentially within telomeric-localized repetitive DNA . This functional difference appears to be due to distinct C-terminal domains on each enzyme .

What methods can detect the interaction between JBP1 and J-modified DNA?

Several techniques can detect JBP1-J-DNA interactions:

  • DNA binding assays: Using purified recombinant JBP1 and J-containing oligonucleotides

  • Electrophoretic mobility shift assay (EMSA): Visualize complex formation between JBP1 and J-DNA

  • Surface plasmon resonance (SPR): Measure binding kinetics and affinity

  • ChIP followed by qPCR or sequencing: Map JBP1 binding to genomic regions containing J

  • Mutation analysis: Testing JBP1 mutants for J-DNA binding capacity

Studies have shown that inactivation of the N-terminal thymidine hydroxylase domain has no effect on J-DNA binding, indicating that JBP1 binding to J-DNA is independent from its thymidine hydroxylase activity .

What approaches can be used to study JBP1 function in different trypanosomatid life cycles?

To investigate JBP1 function across life cycles:

  • Life-stage specific expression analysis: Using JBP1 antibodies for Western blot or immunofluorescence

  • Conditional knockout systems: Inducible depletion of JBP1 at specific life stages

  • Complementation experiments: Reintroducing wild-type or mutant JBP1 into JBP1-null backgrounds

  • Differential ChIP analysis: Compare JBP1 binding patterns across life stages

  • Transcriptomic and proteomic profiling: Assess global changes upon JBP1 deletion

Research has shown significant differences in JBP1 function between different trypanosomatid life stages. For instance, in the trypanosome insect stage that normally lacks base J, JBP2 stimulates site-specific de novo base J synthesis, while JBP1 expression leads to additional J synthesis in these specific regions .

How should researchers quantify and normalize JBP1 protein levels in different samples?

For accurate quantification of JBP1:

  • Western blot quantification:

    • Use housekeeping proteins (tubulin, GAPDH) as loading controls

    • Employ digital image analysis software for densitometry

    • Generate standard curves using recombinant JBP1 if absolute quantification is needed

  • qRT-PCR for transcript analysis:

    • Normalize to reference genes (24S rRNA or tubulin)

    • Use the ΔΔCt method for relative quantification

    • Perform technical triplicates and biological replicates

  • Flow cytometry:

    • Use isotype controls and unstained controls

    • Report median fluorescence intensity (MFI)

    • Include positive and negative control populations

  • Data presentation: Results should be presented as mean ± standard deviation, with appropriate statistical analysis (Student's t-test, with p<0.05 considered significant) .

What approaches can detect changes in JBP1 activity in response to inhibitors or environmental conditions?

To assess JBP1 activity modulation:

  • In vivo inhibition assays:

    • Treat cells with potential TH inhibitors such as dimethyloxoglycine (DMOG) or 2,4-pyridinedicarboxylic acid hydrate

    • Use DMSO as vehicle control

    • Monitor J levels via anti-J DNA immunoblot assay

  • Genomic J quantification:

    • Serially dilute genomic DNA

    • Use anti-J antisera detection followed by secondary antibody-HRP

    • Visualize by enhanced chemiluminescence (ECL)

    • Strip and hybridize with a control probe (β-tubulin gene) to normalize DNA loading

  • hmU detection:

    • Anti-HOMedU immunoprecipitation assay

    • LC-MS/MS analysis with stable isotope-dilution methods

These approaches have been successfully used to demonstrate that inhibitors of Fe²⁺/2-oxoglutarate-dependent dioxygenases can reduce J synthesis, confirming the enzymatic nature of JBP1 .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.